These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 14577954)
1. New antiviral drugs that target herpesvirus helicase primase enzymes. Kleymann G Herpes; 2003 Aug; 10(2):46-52. PubMed ID: 14577954 [TBL] [Abstract][Full Text] [Related]
2. New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease. Kleymann G; Fischer R; Betz UA; Hendrix M; Bender W; Schneider U; Handke G; Eckenberg P; Hewlett G; Pevzner V; Baumeister J; Weber O; Henninger K; Keldenich J; Jensen A; Kolb J; Bach U; Popp A; Mäben J; Frappa I; Haebich D; Lockhoff O; Rübsamen-Waigmann H Nat Med; 2002 Apr; 8(4):392-8. PubMed ID: 11927946 [TBL] [Abstract][Full Text] [Related]
3. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease. Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945 [TBL] [Abstract][Full Text] [Related]
4. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2. Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624 [TBL] [Abstract][Full Text] [Related]
5. Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus. Field HJ; Biswas S Drug Resist Updat; 2011 Feb; 14(1):45-51. PubMed ID: 21183396 [TBL] [Abstract][Full Text] [Related]
6. Helicase primase: targeting the Achilles heel of herpes simplex viruses. Kleymann G Antivir Chem Chemother; 2004 May; 15(3):135-40. PubMed ID: 15266895 [TBL] [Abstract][Full Text] [Related]
7. Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections. Biswas S; Sukla S; Field HJ Future Med Chem; 2014 Jan; 6(1):45-55. PubMed ID: 24358947 [TBL] [Abstract][Full Text] [Related]
8. New anti-HSV therapeutics target the helicase-primase complex. Crumpacker CS; Schaffer PA Nat Med; 2002 Apr; 8(4):327-8. PubMed ID: 11927930 [No Abstract] [Full Text] [Related]
9. Isolation and characterization of herpes simplex virus type 1 resistant to aminothiazolylphenyl-based inhibitors of the viral helicase-primase. Liuzzi M; Kibler P; Bousquet C; Harji F; Bolger G; Garneau M; Lapeyre N; McCollum RS; Faucher AM; Simoneau B; Cordingley MG Antiviral Res; 2004 Dec; 64(3):161-70. PubMed ID: 15550269 [TBL] [Abstract][Full Text] [Related]
10. Mutations close to functional motif IV in HSV-1 UL5 helicase that confer resistance to HSV helicase-primase inhibitors, variously affect virus growth rate and pathogenicity. Biswas S; Tiley LS; Zimmermann H; Birkmann A; Field HJ Antiviral Res; 2008 Oct; 80(1):81-5. PubMed ID: 18539344 [TBL] [Abstract][Full Text] [Related]
11. Novel agents and strategies to treat herpes simplex virus infections. Kleymann G Expert Opin Investig Drugs; 2003 Feb; 12(2):165-83. PubMed ID: 12556212 [TBL] [Abstract][Full Text] [Related]
12. Effects of therapy using a helicase-primase inhibitor (HPI) in mice infected with deliberate mixtures of wild-type HSV-1 and an HPI-resistant UL5 mutant. Sukla S; Biswas S; Birkmann A; Lischka P; Ruebsamen-Schaeff H; Zimmermann H; Field HJ Antiviral Res; 2010 Jul; 87(1):67-73. PubMed ID: 20420855 [TBL] [Abstract][Full Text] [Related]
13. Helicase-primase as a target of new therapies for herpes simplex virus infections. James SH; Larson KB; Acosta EP; Prichard MN Clin Pharmacol Ther; 2015 Jan; 97(1):66-78. PubMed ID: 25670384 [TBL] [Abstract][Full Text] [Related]
14. A single drug-resistance mutation in HSV-1 UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral target. Biswas S; Kleymann G; Swift M; Tiley LS; Lyall J; Aguirre-Hernández J; Field HJ J Antimicrob Chemother; 2008 May; 61(5):1044-7. PubMed ID: 18299638 [TBL] [Abstract][Full Text] [Related]
15. Agents and strategies in development for improved management of herpes simplex virus infection and disease. Kleymann G Expert Opin Investig Drugs; 2005 Feb; 14(2):135-61. PubMed ID: 15757392 [TBL] [Abstract][Full Text] [Related]
16. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1. Wozniak MA; Frost AL; Itzhaki RF Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133 [TBL] [Abstract][Full Text] [Related]
17. Helicase-primase inhibitors for the treatment of herpes simplex virus infections - patent evaluation of WO2023/225162 from Gilead Sciences Inc. Gege C; Kleymann G Expert Opin Ther Pat; 2024 Oct; 34(10):863-872. PubMed ID: 39262042 [TBL] [Abstract][Full Text] [Related]
18. Drugs in development for herpes simplex and varicella zoster virus. Birkmann A; Zimmermann H Clin Pharmacol Ther; 2017 Jul; 102(1):30-32. PubMed ID: 28160282 [TBL] [Abstract][Full Text] [Related]